Title of article
Comparative Proteomics Study of Streptozotocin-induced Diabetic Nephropathy in Rats’ Kidneys Transfected with Adenovirus-mediated Fibromodulin Gene
Author/Authors
Maleki، Akram نويسنده Zanjan Metabolic Disease Research Center, Zanjan University of Medical Sciences , , Ramazani، Ali نويسنده , , Foroutan، Maryam نويسنده Department of Molecular Medicine & Genetics, School of Medicine, Zanjan University of Medical Sciences , , Biglari، Alireza نويسنده Department of Molecular Medicine & Genetics, School of Medicine, Zanjan University of Medical Sciences , , Ranjzad، Parisa نويسنده Vascular Gene Therapy Unit, Research School of Clinical & Laboratory Sciences, Manchester Academic Health Science Centre, The University of Manchester , , Awsat Mellati، Ali نويسنده ,
Issue Information
فصلنامه با شماره پیاپی 21 سال 2014
Pages
9
From page
104
To page
112
Abstract
Background: Transforming Growth Factor-beta (TGF-β) activation appears to be crucial for tissue injury in Diabetic Nephropathy (DN). Fibromodulin, the small leucine-rich proteoglycan, has been proposed to be the potent TGF-β modulator. In this study, the therapeutic effects of fibromodulin in the kidneys of streptozotocin (STZ)-induced diabetic rats were investigated.
Methods: Diabetic rats received intraperitoneal (IP) injections of recombinant adenovirus expression vectors (RAd5) containing fibromodulin (RAd-FMOD) and were killed after 10 weeks. Proteins were isolated from the rat kidney and separated using two-dimensional gel electrophoresis. The differentially expressed proteins were analyzed using Matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
Results: Ten spots were identified using MALDI-TOF-MS. The identified proteins were primarily responsible for cell metabolism, cytoskeleton formation, and oxidative stress. RAd-FMOD treatment markedly attenuated the albuminuria in diabetic rats.
Conclusion: Taken together, these results provide a valuable clue in exploring the mechanism underlying the therapeutic effects of fibromodulin in diabetic nephropathy suggesting that it can be a potential agent in the treatment of this disease.
Journal title
AJMB Avicenna Journal of Medical Biotechnology
Serial Year
2014
Journal title
AJMB Avicenna Journal of Medical Biotechnology
Record number
1983371
Link To Document